At Goodwin, we use law to achieve unprecedented results for our clients. Our 1,000 plus lawyers across the United States, Europe, and Asia excel at complex transactions, high-stakes litigations and world-class advisory services in the financial, life sciences, private equity, real estate, and technology industries. We partner with our clients to practice law with integrity, ingenuity, agility and ambition. To learn more, visit us at www.goodwinlaw.com
Sarah A. Solomon is a partner in the firm’s Technology & Life Sciences Group.
Ms. Solomon represents biotechnology, pharmaceutical, medical device, diagnostic and other life sciences companies in connection with their intellectual property, commercial and M&A transactions. She regularly advises private and public companies on complex strategic collaboration and partnering transactions (such as co-development, joint research and development agreements, patent licenses, strategic alliances and joint ventures); research, development and commercial relationships (such as manufacturing, distribution, supply, clinical trial, university licenses and services arrangements); and mergers and acquisitions (such as product acquisitions, spin-outs and patent portfolio acquisitions). Ms. Solomon also counsels clients in connection with international transactions and relationships in North America, South America, Europe and Asia.
Noelle Dubiansky is an associate in the firm’s Technology & Life Sciences Group. She joined Goodwin in 2014. Ms. Dubiansky represents biotechnology, pharmaceutical, medical device, and other life science companies in a wide range of intellectual property and commercial transactions. She regularly advises private and public companies on complex commercial transactions, including strategic partnerships, licensing, technology acquisition, research and development collaborations, clinical testing, contract services, distribution and manufacturing agreements. Ms. Dubiansky also regularly counsels clients in connection with private financings, public offerings, spin-outs and M&A transactions with respect to intellectual property rights and operational risks. Prior to joining Goodwin, Ms. Dubiansky was an associate in the Life Sciences practice group at Cooley LLP and previously, in the FDA group at Hyman, Phelps & McNamara. While attending law school, Ms. Dubiansky was named an Edward F. Hennessey Scholar.